GenEdit is focused on overcoming the major challenge to genetic medicines: Delivery. We aim to overcome this limitation and enable treatment of a broad range of diseases, having a positive impact on the lives of as many people as possible.
The foundation of our company is our NanoGalaxy platform. NanoGalaxy contains a library spanning thousands of unique non-viral, non-lipid, polymer nanoparticles. Using our iterative screening process, we are able to identify polymer nanoparticles that can deliver the needed genetic medicine payload to the needed tissue to treat disease.
We are focusing our research on the treatment of diseases for which our delivery technology can enable therapeutic options that otherwise may not be possible. We are developing an internal pipeline of therapeutic candidates to treat a range of diseases with high unmet medical need.
Company Details
- Employees
- 55
- Founded
- -
- Address
- 681 Gateway Blvd,
- pa****@****dit.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- genedit.com
- HQ
- South San Francisco, California
Genedit Questions
Genedit's website is genedit.com
Genedit's LinkedIn profile is https://www.linkedin.com/company/genedit
Genedit has
55 employees.
View email and phone details for 55
employees at Genedit.
Genedit's industry is
Biotechnology Research
Genedit's top competitors are
Adverum Biotechnologies,
Kyverna Therapeutics,
Denali Therapeutics,
Genentech,
Slingshot Biosciences,
Bridgebio,
Mammoth Biosciences,
Nutcracker Therapeutics,
Arsenal Biosciences, Inc.,
Jasper Therapeutics.
Genedit's support email address is park@genedit.com
Genedit's categories are Biotechnology Research
Genedit's founding year is 2016
